OpenIcon research & analysis

Information Technology

Stocks Covered
Finance &

Foreseeing value & Offering insight

Seeking Alpha articles by William P. Meyers

Recent and Popular:

Inovio's dBiTEs Technology Data Adds To Buy Conviction [April 23, 2019 at Seeking Alpha]

Syros Pharmaceuticals Platform Undervalued After Dip [April 10, 2019 @ Seeking Alpha]

Verastem Cancer Therapy Should Get Traction, Raise Stock Price [March 23, 2019 @ Seeking Alpha]

Agenus Melts Down With Blockchain [February 26, 2019 @ Seeking Alpha]

Ionis Hits Huntington's Milestone [February 1, 2019 @ Seeking Alpha]

Biotech Bargain Basement Buys: VBL Therapeutics [January 23, 2019 @ Seeking Alpha

I Plan To Keep Bristol-Myers Squibb Stock Issued For Celgene [January 15, 2019 at Seeking Alpha

Biotech Bargain Basement: GlycoMimetics [January 8, 2019 @ Seeking Alpha]

Biotech Bargain Basement: Tetraphase [January 2, 2019 @ Seeking Alpha]

Agenus Wins $1.85 Billion Deal, But Market Cap Is Just $266 Million [December 26, 2018 @ Seeking Alpha]

Ionis Rising on RNA Therapy Optimism [December 14, 2018 @ Seeking Alpha]

Questioning Agios Pharmaceuticals' Future Revenue December 7, 2018

Biogen Outlook For The 2020s November 30, 2018

Celgene's Positives Greatly Outweigh Negatives [November 20, 2018]

Microchip is a Buy on Pullback [August 20, 2018]

Alexion: Priced Right For Long-Term Investors [August 16, 2018 at Seeking Alpha]

Regeneron: A Buy On Dupixent And Pipeline [August 15, 2018 at Seeking Alpha]

Inovio: Time To Think About 2020 [July 11, 2018]

Star Bulk Undervalued On Rates, Oaktree Stock Sale [July 2, 2018]

Amgen Should Rebound [June 20, 2018]

Five Reasons Celgene Will Recover [Seeking Alpha, June 1, 2018]

Immune Checkpoint Inhibitors

Biotechnology stocks covered

Biotech Research Help page

The Accounting System: The New Money Cloud

Links to Quarterly Results Notes

Dissecting the Bull blog

Finance and Economics Commentary


(experimental): Random Stock Picker

Machine Understanding (AI)